Chemical Formula: C39H78NO8P

Chemical Formula C39H78NO8P

Found 149 metabolite its formula value is C39H78NO8P

PC(15:0/16:0)

(2-{[(2R)-2-(hexadecanoyloxy)-3-(pentadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C39H78NO8P (719.5464757999999)


PC(15:0/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/16:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(15:0/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/16:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(18:0/16:0)

(2-aminoethoxy)[(2R)-2-(hexadecanoyloxy)-3-(octadecanoyloxy)propoxy]phosphinic acid

C39H78NO8P (719.5464757999999)


PE(18:0/16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/16:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(18:0/16:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(18:0/16:0), in particular, consists of one octadecanoyl chain to the C-1 atom, and one hexadecanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PC(16:0/15:0)

(2-{[(2R)-3-(hexadecanoyloxy)-2-(pentadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C39H78NO8P (719.5464757999999)


PC(16:0/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/15:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(16:0/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/15:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(16:0/18:0)

(2-aminoethoxy)[(2R)-3-(hexadecanoyloxy)-2-(octadecanoyloxy)propoxy]phosphinic acid

C39H78NO8P (719.5464757999999)


PE(16:0/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:0/18:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of stearic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(16:0/18:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(16:0/18:0), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one octadecanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(14:0/20:0)

(2-aminoethoxy)[(2R)-2-(icosanoyloxy)-3-(tetradecanoyloxy)propoxy]phosphinic acid

C39H78NO8P (719.5464757999999)


PE(14:0/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:0/20:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(14:0/20:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(14:0/20:0), in particular, consists of one tetradecanoyl chain to the C-1 atom, and one eicosanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE(20:0/14:0)

(2-aminoethoxy)[(2R)-3-(icosanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphinic acid

C39H78NO8P (719.5464757999999)


PE(20:0/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:0/14:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of myristic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(20:0/14:0) is a phosphatidylethanolamine. It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 atoms. PE(20:0/14:0), in particular, consists of one eicosanoyl chain to the C-1 atom, and one tetradecanoyl to the C-2 atom. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

   

PE-NMe2(16:0/16:0)

[(2R)-2,3-bis(hexadecanoyloxy)propoxy][2-(dimethylamino)ethoxy]phosphinic acid

C39H78NO8P (719.5464757999999)


PE-NMe2(16:0/16:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(16:0/16:0), in particular, consists of two hexadecanoyl chain at positions C-1 and C2. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. PE-NMe2(16:0/16:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. (Lipid Library, Lipid MAPS) [HMDB]

   

PE-NMe(15:0/18:0)

[2-(methylamino)ethoxy][2-(octadecanoyloxy)-3-(pentadecanoyloxy)propoxy]phosphinic acid

C39H78NO8P (719.5464757999999)


PE-NMe(15:0/18:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(15:0/18:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of stearic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(18:0/15:0)

[2-(methylamino)ethoxy][3-(octadecanoyloxy)-2-(pentadecanoyloxy)propoxy]phosphinic acid

C39H78NO8P (719.5464757999999)


PE-NMe(18:0/15:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:0/15:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(14:0/18:0)

[2-(dimethylamino)ethoxy][2-(octadecanoyloxy)-3-(tetradecanoyloxy)propoxy]phosphinic acid

C39H78NO8P (719.5464757999999)


PE-NMe2(14:0/18:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(14:0/18:0), in particular, consists of one tetradecanoyl chain to the C-1 atom, and one octadecanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe2(18:0/14:0)

[2-(dimethylamino)ethoxy][3-(octadecanoyloxy)-2-(tetradecanoyloxy)propoxy]phosphinic acid

C39H78NO8P (719.5464757999999)


PE-NMe2(18:0/14:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:0/14:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   
   

Phosphatidylethanolamine 18:0-16:0

Phosphatidylethanolamine 18:0-16:0

C39H78NO8P (719.5464757999999)


   
   

PC 31:0

1-hexadecanoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C39H78NO8P (719.5464757999999)


Found in mouse lung; TwoDicalId=174; MgfFile=160901_Lung_AA_Neg_17_never; MgfId=981

   

PE 34:0

1-pentadecanoyl-2-nonadecanoyl-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


Found in mouse brain; TwoDicalId=365; MgfFile=160720_brain_AA_18_Neg; MgfId=1568

   

PE(18:0/16:0)[U]

Octadecanoic acid, 3-[[(2-aminoethoxy)hydroxyphosphinyl]oxy]-2-[(1-oxohexadecyl)oxy]propyl ester

C39H78NO8P (719.5464757999999)


   

PC(13:0/18:0)[U]

3,5,8-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotridecyl)oxy]methyl]-, inner salt, 4-oxide

C39H78NO8P (719.5464757999999)


   

PC(14:0/17:0)[U]

3,5,8-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotetradecyl)oxy]methyl]-, inner salt, 4-oxide

C39H78NO8P (719.5464757999999)


   

PC(15:0/16:0)[U]

3,5,8-Trioxa-4-phosphatetracosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxopentadecyl)oxy]methyl]-, inner salt, 4-oxide

C39H78NO8P (719.5464757999999)


   

PC(16:0/15:0)[U]

3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotetradecyl)oxy]-, inner salt, 4-oxide, (1)-

C39H78NO8P (719.5464757999999)


   

PC(17:0/14:0)[U]

3,5,9-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotetradecyl)oxy]-, inner salt, 4-oxide

C39H78NO8P (719.5464757999999)


   

PC(18:0/13:0)[U]

3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotridecyl)oxy]-, inner salt, 4-oxide

C39H78NO8P (719.5464757999999)


   

PC(19:0/12:0)

3,5,9-Trioxa-4-phosphaoctacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxododecyl)oxy]-, inner salt, 4-oxide, (R)-

C39H78NO8P (719.5464757999999)


   

PC(20:0/11:0)

3,5,9-Trioxa-4-phosphanonacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoundecyl)oxy]-, inner salt, 4-oxide, (R)-

C39H78NO8P (719.5464757999999)


   

PC(21:0/10:0)

3,5,9-Trioxa-4-phosphatriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxodecyl)oxy]-, inner salt, 4-oxide, (R)-

C39H78NO8P (719.5464757999999)


   

PC(9:0/22:0)

3,5,8-Trioxa-4-phosphatriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxononyl)oxy]methyl]-, inner salt, 4-oxide, (R)-

C39H78NO8P (719.5464757999999)


   

PE(17:0/17:0)[U]

Heptadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester

C39H78NO8P (719.5464757999999)


   

PE(20:0/14:0)[U]

1-Eicosanoyl-2-tetradecanoyl-sn-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


   

PE(19:0/15:0)[U]

1-nonadecanoyl-2-pentadecanoyl-sn-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


   

PE(13:0/21:0)[U]

1-tridecanoyl-2-heneicosanoyl-sn-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


   

PE(16:0/18:0)[U]

Octadecanoic acid, (1R)-1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester (9CI)

C39H78NO8P (719.5464757999999)


   

PE(14:0/20:0)[U]

1-Tetradecanoyl-2-eicosanoyl-sn-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


   

GPEtnNMe2(16:0/16:0)

Hexadecanoic acid, 1-(3-hydroxy-7-methyl-2,4-dioxa-7-aza-3-phosphaoct-1-yl)-1,2-ethanediyl ester, P-oxide, (R)-

C39H78NO8P (719.5464757999999)


   

GPEtnNMe2(16:0/16:0)[U]

Hexadecanoic acid, 1-(3-hydroxy-7-methyl-3-oxido-2,4-dioxa-7-aza-3-phosphaoct-1-yl)-1,2-ethanediyl ester, (1)-

C39H78NO8P (719.5464757999999)


   

Lecithin

1-Palmitoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C39H78NO8P (719.5464757999999)


   

PE(34:0)

1-Arachidonyl-2-myristoyl-sn-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


   

PC(12:0/19:0)

1-dodecanoyl-2-nonadecanoyl-glycero-3-phosphocholine

C39H78NO8P (719.5464757999999)


   

PC(13:0/18:0)

1-tridecanoyl-2-octadecanoyl-glycero-3-phosphocholine

C39H78NO8P (719.5464757999999)


   

PC(14:0/17:0)

1-tetradecanoyl-2-heptadecanoyl-glycero-3-phosphocholine

C39H78NO8P (719.5464757999999)


   

PC(17:0/14:0)

1-heptadecanoyl-2-tetradecanoyl-glycero-3-phosphocholine

C39H78NO8P (719.5464757999999)


   

PC(18:0/13:0)

1-octadecanoyl-2-tridecanoyl-glycero-3-phosphocholine

C39H78NO8P (719.5464757999999)


   

PE(22:0/12:0)

1-docosanoyl-2-dodecanoyl-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


   

PE(21:0/13:0)

1-heneicosanoyl-2-tridecanoyl-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


   

PE(19:0/15:0)

1-nonadecanoyl-2-pentadecanoyl-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


   

PE(17:0/17:0)

1,2-DIHEPTADECANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE

C39H78NO8P (719.5464757999999)


   

PE(15:0/19:0)

1-pentadecanoyl-2-nonadecanoyl-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


   

PE(13:0/21:0)

1-tridecanoyl-2-heneicosanoyl-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


   

PE(12:0/22:0)

1-dodecanoyl-2-docosanoyl-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


   

PE-NMe2 32:0

Hexadecanoic acid, 1-(3-hydroxy-7-methyl-2,4-dioxa-7-aza-3-phosphaoct-1-yl)-1,2-ethanediyl ester, P-oxide, (R)-

C39H78NO8P (719.5464757999999)


   

1,2-DIHEPTADECANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE

[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] heptadecanoate

C39H78NO8P (719.5464757999999)


   

Octadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester

Octadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl ester

C39H78NO8P (719.5464757999999)


   

(2-Hexadecanoyloxy-3-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hexadecanoyloxy-3-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

1,2-dipalmitoyl-phosphatidyl-N-dimethylethanolamine

1,2-dipalmitoyl-phosphatidyl-N-dimethylethanolamine

C39H78NO8P (719.5464757999999)


   

2-Azaniumylethyl (2R)-2,3-bis(heptadecanoyloxy)propyl phosphate

2-Azaniumylethyl (2R)-2,3-bis(heptadecanoyloxy)propyl phosphate

C39H78NO8P (719.5464757999999)


   

2-Ammonioethyl (2R)-3-(palmitoyloxy)-2-(stearoyloxy)propyl phosphate

2-Ammonioethyl (2R)-3-(palmitoyloxy)-2-(stearoyloxy)propyl phosphate

C39H78NO8P (719.5464757999999)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] pentacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] pentacosanoate

C39H78NO8P (719.5464757999999)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] henicosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] henicosanoate

C39H78NO8P (719.5464757999999)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] icosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] icosanoate

C39H78NO8P (719.5464757999999)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] nonadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] nonadecanoate

C39H78NO8P (719.5464757999999)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] docosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] docosanoate

C39H78NO8P (719.5464757999999)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] tetracosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] tetracosanoate

C39H78NO8P (719.5464757999999)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] tricosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] tricosanoate

C39H78NO8P (719.5464757999999)


   

(3-Dodecanoyloxy-2-nonadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Dodecanoyloxy-2-nonadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

(2-Octadecanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Octadecanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

(2-Heptadecanoyloxy-3-tetradecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Heptadecanoyloxy-3-tetradecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

(2-Icosanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Icosanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] hexacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] hexacosanoate

C39H78NO8P (719.5464757999999)


   

(2-Hexacosanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hexacosanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

(3-Butanoyloxy-2-heptacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Butanoyloxy-2-heptacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

(3-Decanoyloxy-2-henicosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Decanoyloxy-2-henicosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] heptacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] heptacosanoate

C39H78NO8P (719.5464757999999)


   

(3-Heptanoyloxy-2-tetracosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Heptanoyloxy-2-tetracosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

(2-Docosanoyloxy-3-nonanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Docosanoyloxy-3-nonanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

(3-Octanoyloxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Octanoyloxy-2-tricosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

(3-Hexanoyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Hexanoyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] docosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] docosanoate

C39H78NO8P (719.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] tricosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] tricosanoate

C39H78NO8P (719.5464757999999)


   

[(2S)-2-decanoyloxy-3-henicosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-decanoyloxy-3-henicosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-decanoyloxypropyl] tetracosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-decanoyloxypropyl] tetracosanoate

C39H78NO8P (719.5464757999999)


   

[(2S)-3-octadecanoyloxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-octadecanoyloxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] tetracosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] tetracosanoate

C39H78NO8P (719.5464757999999)


   

[(2S)-3-icosanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-icosanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C39H78NO8P (719.5464757999999)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] icosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] icosanoate

C39H78NO8P (719.5464757999999)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] henicosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] henicosanoate

C39H78NO8P (719.5464757999999)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] tricosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] tricosanoate

C39H78NO8P (719.5464757999999)


   

1-Hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphoethanolamine

1-Hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and octadecanoyl (stearoyl) respectively.

   

1-octadecanoyl-2-hexadecanoyl-glycero-3-phosphoethanolamine

1-octadecanoyl-2-hexadecanoyl-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


   

1-pentadecanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine

1-pentadecanoyl-2-hexadecanoyl-sn-glycero-3-phosphocholine

C39H78NO8P (719.5464757999999)


A phosphatidylcholine 31:0 in which the fatty acyl groups at positions 1 and 2 are specified as pentadecanoyl and hexadecanoyl respectively

   
   

1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphoethanolamine zwitterion

1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphoethanolamine zwitterion

C39H78NO8P (719.5464757999999)


A phosphatidylethanolamine 34:1 zwitterion obtained by transfer of a proton from the phosphate to the amino group of 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphoethanolamine.

   

1-decanoyl-2-heneicosanoyl-sn-glycero-3-phosphocholine

1-decanoyl-2-heneicosanoyl-sn-glycero-3-phosphocholine

C39H78NO8P (719.5464757999999)


   

1-nonadecanoyl-2-pentadecanoyl-glycero-3-phosphoethanolamine

1-nonadecanoyl-2-pentadecanoyl-glycero-3-phosphoethanolamine

C39H78NO8P (719.5464757999999)


   

dimethylphosphatidylethanolamine 32:0

dimethylphosphatidylethanolamine 32:0

C39H78NO8P (719.5464757999999)


A glycerophosphoethanolamine that is phosphatidylethanolamine 32:0 in which the two amino hydrogens have been replaced by methyl groups

   

phosphatidylcholine 31:0

phosphatidylcholine 31:0

C39H78NO8P (719.5464757999999)


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 31 carbons and no double bonds.

   

phosphatidylethanolamine 34:0

phosphatidylethanolamine 34:0

C39H78NO8P (719.5464757999999)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 34 carbons in total with 0 double bonds.

   

MePC(30:0)

MePC(16:0_14:0)

C39H78NO8P (719.5464757999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

dMePE(32:0)

dMePE(16:0_16:0)

C39H78NO8P (719.5464757999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

BisMePE(32:0)

BisMePE(16:0_16:0)

C39H78NO8P (719.5464757999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved